Chimerix Stock Price

-0.34 (-3.66%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Chimerix Inc CMRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.34 -3.66% 8.96 15:23:11
Open Price Low Price High Price Close Price Prev Close
9.31 8.93 9.53 9.30
Bid Price Ask Price Spread News
8.94 8.97 0.03 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,628 209,053 $ 9.22 $ 1,926,987 1,594,873 1.19 - 11.5696
Last Trade Time Type Quantity Stock Price Currency
15:23:02 1 $ 8.96 USD

Chimerix Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 639.36M 71.36M 57.36M $ 12.52M $ - -1.95 -18.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Chimerix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CMRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.8010.898.159.77720,036-0.84-8.57%
1 Month9.9511.56968.1510.18667,060-0.99-9.95%
3 Months5.0011.56964.608.691,156,7653.9679.2%
6 Months2.3211.56962.226.87799,1666.64286.21%
1 Year1.6211.56961.194.76767,5127.34453.09%
3 Years5.4311.56961.193.72503,2203.5365.01%
5 Years5.4411.56961.194.21489,9503.5264.71%

Chimerix Description

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes a treatment for acute myeloid leukemia (or AML) and an antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment--pharmaceuticals.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.